Earnings Reportpositive
Earnings Report
- Company
- UroGen Pharma Ltd. (URGN)
Other upcoming events for URGN
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Single-arm, Multicenter Study to Evaluate the Efficacy and Safety of UGN-103, a Novel For
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of UGN-102 as Primary C
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Single-arm, Multicenter Study to Evaluate the Efficacy and Safety of UGN-104, a Novel For
Patent ExpiryPatent/Exclusivity Expiry: JELMYTO
Patent ExpiryPatent/Exclusivity Expiry: ZUSDURI
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.